Cocaine detoxification by human plasma butyrylcholinesterase

被引:81
|
作者
Lynch, TJ
Mattes, CE
Singh, A
Bradley, RM
Brady, RO
Dretchen, KL
机构
[1] PHARMAVENE INC, GAITHERSBURG, MD 20850 USA
[2] GEORGETOWN UNIV, MED CTR, DEPT PHARMACOL, WASHINGTON, DC 20007 USA
关键词
D O I
10.1006/taap.1997.8187
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The ability of human plasma butyrylcholinesterase (BChE) to detoxify cocaine in vivo was evaluated. Intravenous administration of BChE, at doses sufficient to increase the plasma levels of the enzyme as much as 800-fold, produced no adverse effects on the cardiovascular, autonomic, or central nervous systems of rats. Most of the enzyme could be recovered in the plasma immediately after administration and remained active with a beta-t 1/2 of 21.6 +/- 2.4 hr. Pretreatment of chloralose-urethane anesthetized rats with BChE, 0.1-7.8 mg/kg, decreased the hypertensive and arrhythmogenic effects produced by cocaine and increased the lethal dose of cocaine by three-to fourfold. Treatment of conscious rats with 1 and 10 mg/kg BChE decreased the incidence of seizures and deaths produced by a prior dose of cocaine (80 mg/kg, ip), These results suggest that BChE would provide a safe and highly efficacious treatment for cocaine intoxication. (C) 1997 Academic Press.
引用
收藏
页码:363 / 371
页数:9
相关论文
共 50 条
  • [31] A cocaine hydrolase engineered from human butyrylcholinesterase selectively blocks cocaine toxicity and reinstatement of drug seeking in rats
    Brimijoin, Stephen
    Gao, Yang
    Anker, Justin J.
    Gliddon, Luke A.
    LaFleur, David
    Shah, R.
    Zhao, Qinghai
    Singh, M.
    Carroll, Marilyn E.
    NEUROPSYCHOPHARMACOLOGY, 2008, 33 (11) : 2715 - 2725
  • [32] Prolonged Toxic Effects After Cocaine Challenge in Butyrylcholinesterase/Plasma Carboxylesterase Double Knockout Mice: A Model for Butyrylcholinesterase-Deficient Humans
    Duysen, Ellen G.
    Lockridge, Oksana
    DRUG METABOLISM AND DISPOSITION, 2011, 39 (08) : 1321 - 1323
  • [33] COCAINE DETOXIFICATION WITH BROMOCRIPTINE AND DESIPRAMINE
    GIANNINI, AJ
    LOISELLE, RH
    GIANNINI, MC
    JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 27 (09): : 705 - 705
  • [34] Butyrylcholinesterase levels and subjective effects of smoked cocaine in healthy cocaine users
    Askalsky, Paula
    Kalapatapu, Raj K.
    Foltin, Richard W.
    Comer, Sandra D.
    AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2015, 41 (02): : 161 - 165
  • [35] BROMOCRIPTINE AND AMANTADINE IN COCAINE DETOXIFICATION
    GIANNINI, AJ
    FOLTS, DJ
    FEATHER, JN
    SULLIVAN, BS
    PSYCHIATRY RESEARCH, 1989, 29 (01) : 11 - 16
  • [36] Plasma butyrylcholinesterase activity and cocaine half-life differ significantly in rhesus and squirrel monkeys
    Carmona, GN
    Baum, I
    Schindler, CW
    Goldberg, SR
    Jufer, R
    Cone, E
    Slaughter, E
    Belendiuk, GW
    Gorelick, DA
    LIFE SCIENCES, 1996, 59 (11) : 939 - 943
  • [37] INVITRO DETOXIFICATION OF SOMAN IN HUMAN-PLASMA
    DEBISSCHOP, HC
    VANDRIESSCHE, EE
    ALBERTY, MLM
    WILLEMS, JL
    FUNDAMENTAL AND APPLIED TOXICOLOGY, 1985, 5 (06): : S175 - S179
  • [38] Kinetic characterization of high-activity mutants of human butyrylcholinesterase for the cocaine metabolite norcocaine
    Zhan, Max
    Hou, Shurong
    Zhan, Chang-Guo
    Zheng, Fang
    BIOCHEMICAL JOURNAL, 2014, 457 : 197 - 206
  • [39] Cocaine and butyrylcholinesterase (BChE): Determination of enzymatic parameters
    Mattes, C
    Bradley, R
    Slaughter, E
    Browne, S
    LIFE SCIENCES, 1996, 58 (13) : PL257 - PL261
  • [40] Re-engineering butyrylcholinesterase as a cocaine hydrolase
    Sun, H
    Pang, YP
    Lockridge, O
    Brimijoin, S
    MOLECULAR PHARMACOLOGY, 2002, 62 (02) : 220 - 224